Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia

NCT01380587 is registered in ClinicalTrials.gov with Hospital Universitario Dr. Jose E. Gonzalez as lead sponsor.

NCT NCT01380587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01380587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
Lead sponsor
Hospital Universitario Dr. Jose E. Gonzalez
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
September 30, 2012
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia